Skip to content
10-Q

Quarterly Report

MAZE THERAPEUTICS, INC. MAZE

0001193125-25-269689

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 3, 2025 48.12M sh
Shares Diluted Q3 2025 · Sep 30, 2025 45.78M sh
Shares Diluted Q3 2025 · Sep 30, 2025 39.46M sh
Shares Diluted Q3 2025 · Sep 30, 2024 2.42M sh
Shares Diluted Q3 2025 · Sep 30, 2024 3.39M sh
Capex Q3 2025 · Sep 30, 2025 $760K
Capex Q3 2025 · Sep 30, 2024 $542K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$84.21M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $98.41M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $316.77M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $196.81M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $149.61M
Stockholders Equity Q3 2025 · Sep 30, 2025 $379.44M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$311.18M
Current Liabilities Q3 2025 · Sep 30, 2025 $22.11M
Current Liabilities Q3 2025 · Dec 31, 2024 $20.67M
Total Liabilities Q3 2025 · Sep 30, 2025 $42.62M
Total Liabilities Q3 2025 · Dec 31, 2024 $43.64M
Current Assets Q3 2025 · Sep 30, 2025 $391.3M
Current Assets Q3 2025 · Dec 31, 2024 $201.67M
Total Assets Q3 2025 · Sep 30, 2025 $422.06M
Total Assets Q3 2025 · Dec 31, 2024 $240.54M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.66
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.45
Eps Diluted Q3 2025 · Sep 30, 2024 −$10.25
Eps Diluted Q3 2025 · Sep 30, 2024 $2.67
Eps Basic Q3 2025 · Sep 30, 2025 −$0.66
Eps Basic Q3 2025 · Sep 30, 2025 −$2.45
Eps Basic Q3 2025 · Sep 30, 2024 −$10.25
Eps Basic Q3 2025 · Sep 30, 2024 $3.49
Sga Expense Q3 2025 · Sep 30, 2025 $7.78M
Sga Expense Q3 2025 · Sep 30, 2025 $23.96M
Sga Expense Q3 2025 · Sep 30, 2024 $6.87M
Sga Expense Q3 2025 · Sep 30, 2024 $18.91M
Rd Expense Q3 2025 · Sep 30, 2025 $25.19M
Rd Expense Q3 2025 · Sep 30, 2025 $80.88M
Rd Expense Q3 2025 · Sep 30, 2024 $19.86M
Rd Expense Q3 2025 · Sep 30, 2024 $61.28M
Net Income Q3 2025 · Sep 30, 2025 −$30.09M
Net Income Q3 2025 · Sep 30, 2025 −$96.55M
Net Income Q3 2025 · Jun 30, 2025 −$33.68M
Net Income Q3 2025 · Mar 31, 2025 −$32.79M
Net Income Q3 2025 · Sep 30, 2024 −$24.75M
Net Income Q3 2025 · Sep 30, 2024 $81.81M
Net Income Q3 2025 · Jun 30, 2024 $139.06M
Net Income Q3 2025 · Mar 31, 2024 −$32.49M
Operating Income Q3 2025 · Sep 30, 2025 −$32.97M
Operating Income Q3 2025 · Sep 30, 2025 −$104.84M
Operating Income Q3 2025 · Sep 30, 2024 −$24.23M
Operating Income Q3 2025 · Sep 30, 2024 $87.31M
Revenue Q3 2025 · Sep 30, 2024 $2.5M
Revenue Q3 2025 · Sep 30, 2024 $167.5M